Literature DB >> 28676700

The multifaceted roles of PARP1 in DNA repair and chromatin remodelling.

Arnab Ray Chaudhuri1,2, André Nussenzweig2.   

Abstract

Cells are exposed to various endogenous and exogenous insults that induce DNA damage, which, if unrepaired, impairs genome integrity and leads to the development of various diseases, including cancer. Recent evidence has implicated poly(ADP-ribose) polymerase 1 (PARP1) in various DNA repair pathways and in the maintenance of genomic stability. The inhibition of PARP1 is therefore being exploited clinically for the treatment of various cancers, which include DNA repair-deficient ovarian, breast and prostate cancers. Understanding the role of PARP1 in maintaining genome integrity is not only important for the design of novel chemotherapeutic agents, but is also crucial for gaining insights into the mechanisms of chemoresistance in cancer cells. In this Review, we discuss the roles of PARP1 in mediating various aspects of DNA metabolism, such as single-strand break repair, nucleotide excision repair, double-strand break repair and the stabilization of replication forks, and in modulating chromatin structure.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28676700      PMCID: PMC6591728          DOI: 10.1038/nrm.2017.53

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  171 in total

1.  Poly(ADP-ribose) (PAR) polymer is a death signal.

Authors:  Shaida A Andrabi; No Soo Kim; Seong-Woon Yu; Hongmin Wang; David W Koh; Masayuki Sasaki; Judith A Klaus; Takashi Otsuka; Zhizheng Zhang; Raymond C Koehler; Patricia D Hurn; Guy G Poirier; Valina L Dawson; Ted M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

2.  Histone H3 and H4 ubiquitylation by the CUL4-DDB-ROC1 ubiquitin ligase facilitates cellular response to DNA damage.

Authors:  Hengbin Wang; Ling Zhai; Jun Xu; Heui-Yun Joo; Sarah Jackson; Hediye Erdjument-Bromage; Paul Tempst; Yue Xiong; Yi Zhang
Journal:  Mol Cell       Date:  2006-05-05       Impact factor: 17.970

Review 3.  Targeting homologous recombination repair defects in cancer.

Authors:  Bastiaan Evers; Thomas Helleday; Jos Jonkers
Journal:  Trends Pharmacol Sci       Date:  2010-07-02       Impact factor: 14.819

4.  Essential role for DNA-PK-mediated phosphorylation of NR4A nuclear orphan receptors in DNA double-strand break repair.

Authors:  Michal Malewicz; Banafsheh Kadkhodaei; Nigel Kee; Nikolaos Volakakis; Ulf Hellman; Kristina Viktorsson; Chuen Yan Leung; Benjamin Chen; Rolf Lewensohn; Dik C van Gent; David J Chen; Thomas Perlmann
Journal:  Genes Dev       Date:  2011-10-01       Impact factor: 11.361

5.  Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair.

Authors:  Eva Petermann; Manuel Luís Orta; Natalia Issaeva; Niklas Schultz; Thomas Helleday
Journal:  Mol Cell       Date:  2010-02-26       Impact factor: 17.970

6.  Poly(ADP-ribose) polymerase (PARP-1) has a controlling role in homologous recombination.

Authors:  Niklas Schultz; Elena Lopez; Nasrollah Saleh-Gohari; Thomas Helleday
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

7.  An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III.

Authors:  K W Caldecott; C K McKeown; J D Tucker; S Ljungquist; L H Thompson
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

8.  The protein kinase CK2 facilitates repair of chromosomal DNA single-strand breaks.

Authors:  Joanna I Loizou; Sherif F El-Khamisy; Anastasia Zlatanou; David J Moore; Douglas W Chan; Jun Qin; Stefania Sarno; Flavio Meggio; Lorenzo A Pinna; Keith W Caldecott
Journal:  Cell       Date:  2004-04-02       Impact factor: 41.582

9.  Disruption of PARP1 function inhibits base excision repair of a sub-set of DNA lesions.

Authors:  Pamela Reynolds; Sarah Cooper; Martine Lomax; Peter O'Neill
Journal:  Nucleic Acids Res       Date:  2015-03-26       Impact factor: 16.971

10.  Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors.

Authors:  Junko Murai; Shar-yin N Huang; Benu Brata Das; Amelie Renaud; Yiping Zhang; James H Doroshow; Jiuping Ji; Shunichi Takeda; Yves Pommier
Journal:  Cancer Res       Date:  2012-11-01       Impact factor: 13.312

View more
  369 in total

1.  Suppressing PARylation by 2',5'-oligoadenylate synthetase 1 inhibits DNA damage-induced cell death.

Authors:  Anna A Kondratova; HyeonJoo Cheon; Beihua Dong; Elise G Holvey-Bates; Metis Hasipek; Irina Taran; Christina Gaughan; Babal K Jha; Robert H Silverman; George R Stark
Journal:  EMBO J       Date:  2020-04-23       Impact factor: 11.598

Review 2.  Profiles of Radioresistance Mechanisms in Prostate Cancer.

Authors:  Luksana Chaiswing; Heidi L Weiss; Rani D Jayswal; Daret K St Clair; Natasha Kyprianou
Journal:  Crit Rev Oncog       Date:  2018

3.  Parp3 promotes long-range end joining in murine cells.

Authors:  Jacob V Layer; J Patrick Cleary; Alexander J Brown; Kristen E Stevenson; Sara N Morrow; Alexandria Van Scoyk; Rafael B Blasco; Elif Karaca; Fei-Long Meng; Richard L Frock; Trevor Tivey; Sunhee Kim; Hailey Fuchs; Roberto Chiarle; Frederick W Alt; Steven A Roberts; David M Weinstock; Tovah A Day
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-13       Impact factor: 11.205

Review 4.  Molecular Mechanisms of Arsenic-Induced Disruption of DNA Repair.

Authors:  Lok Ming Tam; Nathan E Price; Yinsheng Wang
Journal:  Chem Res Toxicol       Date:  2020-02-07       Impact factor: 3.739

5.  Chromatin regulators and their impact on DNA repair and G2 checkpoint recovery.

Authors:  Veronique A J Smits; Ignacio Alonso-de Vega; Daniël O Warmerdam
Journal:  Cell Cycle       Date:  2020-07-30       Impact factor: 4.534

6.  Specific Binding of snoRNAs to PARP-1 Promotes NAD+-Dependent Catalytic Activation.

Authors:  Dan Huang; Dae-Seok Kim; W Lee Kraus
Journal:  Biochemistry       Date:  2020-04-17       Impact factor: 3.162

7.  Risk-Associated Long Noncoding RNA FOXD3-AS1 Inhibits Neuroblastoma Progression by Repressing PARP1-Mediated Activation of CTCF.

Authors:  Xiang Zhao; Dan Li; Dandan Huang; Huajie Song; Hong Mei; Erhu Fang; Xiaojing Wang; Feng Yang; Liduan Zheng; Kai Huang; Qiangsong Tong
Journal:  Mol Ther       Date:  2017-12-22       Impact factor: 11.454

Review 8.  Clinically Applicable Inhibitors Impacting Genome Stability.

Authors:  Anu Prakash; Juan F Garcia-Moreno; James A L Brown; Emer Bourke
Journal:  Molecules       Date:  2018-05-13       Impact factor: 4.411

9.  PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness.

Authors:  Jianfeng Shen; Wei Zhao; Zhenlin Ju; Lulu Wang; Yang Peng; Marilyne Labrie; Timothy A Yap; Gordon B Mills; Guang Peng
Journal:  Cancer Res       Date:  2018-11-27       Impact factor: 12.701

10.  Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies.

Authors:  Leonard J Appleman; Jan H Beumer; Yixing Jiang; Yan Lin; Fei Ding; Shannon Puhalla; Leigh Swartz; Taofeek K Owonikoko; R Donald Harvey; Ronald Stoller; Daniel P Petro; Hussein A Tawbi; Athanassios Argiris; Sandra Strychor; Marie Pouquet; Brian Kiesel; Alice P Chen; David Gandara; Chandra P Belani; Edward Chu; Suresh S Ramalingam
Journal:  Cancer Chemother Pharmacol       Date:  2019-09-23       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.